Atlas Trials

PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Clinical trial NCT02905942 · UNKNOWN

Trial details

NCT number
NCT02905942
Sponsor
Peking University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Lymphoma
Start date
2015-12-01
Primary completion
2018-12-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.